Atrial Fibrillation Accreditation
Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and is reaching epidemic proportions. A 2017 issue of the Journal of the American College of Cardiology stated that there are nearly 7 million people currently in the US that have AF and it is projected that, by 2050, nearly 16 million will have AF. The situation is even more alarming when you consider that AF is responsible for nearly 25% of all reported strokes. The current annual cost of AF care in the U.S. is over $6 billion and nearly $26 billion when co-morbidities and indirect costs are considered.
With this growing clinical and economic burden, hospitals are looking for ways to improve their delivery of care to this AF patient population.